observed high expression of Foxp3, IL-2RA, and IKZF2 in tumor-infiltrating CD4+Treg, as well as increased expression of CTLA4, TIGIT, and TNFRSF9 in tumor-infiltrating CD4+Treg in NSCLC specimens. This evidence concerns the gene CD4 and neoplasm.